Stock DARE DARÉ BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Daré Bioscience, Inc.

Equities

DARE

US23666P1012

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-03 pm EDT 		5-day change 1st Jan Change
0.3112 USD -0.26% Intraday chart for Daré Bioscience, Inc. +1.73% +0.71%
Apr. 30 Daré Bioscience, Inc. Closes Royalty Monetization Transaction with XOMA (US) LLC CI
Apr. 30 XOMA Corporation completed the acquisition of three First-in-Category Assets of Daré Bioscience, Inc. for $22 million. CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Trims Price Target on Dare Bioscience to $6 From $7, Keeps Buy Rating
MT
HC Wainwright Raises Price Target on Dare Bioscience to $7 From $6, Reiterates Buy Rating
MT
JonesTrading Starts Dare Bioscience at Buy With $6 Price Target
MT
Roth Capital Raises Price Target for Dare Bioscience to $17 From $11, Maintains Buy Rating
MT
HC Wainwright Adjusts Dare Bioscience's Price Target to $6 from $5, Keeps Buy Rating
MT
DARE BIOSCIENCE : Roth Capital Adjusts Price Target on Dare Bioscience to $11 From $9, Maintains Buy Rating
MT
DARE BIOSCIENCE : HC Wainwright Initiates Coverage on Dare Bioscience With Buy Rating, $5 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DARE Stock
  4. News Daré Bioscience, Inc.
  5. Analyst Reco.